DHT

Global and China Hybrid Electric Vehicle (HEV) Research Report 2023-2024: Dedicated Hybrid Engines (DHE) with Thermal Efficiency of 45% have been Mass-Produced, and Industrial Upgrade is Imminent - ResearchAndMarkets.com

Retrieved on: 
Friday, March 15, 2024
EV, Electric Vehicles, Green Technology, Environment, Automotive, IAA, DHT, Bev, GM, BYD, Great Wall of China, BEV, Li Auto, Original equipment manufacturer, Volkswagen, Research, Anxiety, Ford, BorgWarner, Carbon, Geely, ICE, HEM, Research report, HEV, Dongfeng, GAC, DHE, PHEV, REEV, Electric motor

The "Global and China Hybrid Electric Vehicle (HEV) Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global and China Hybrid Electric Vehicle (HEV) Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.
  • As new models continue to emerge, the sales of plug-in/extended-range hybrid electric passenger cars will be on the rise.
  • It is expected that by 2025, plug-in/extended-range hybrid electric passenger cars will take up 40% of the new energy passenger car sales in China.
  • Dedicated hybrid engines (DHE) with thermal efficiency of 45% have been mass-produced, and industrial upgrade is imminent.

Journal of Pharmaceutical Analysis (JPA) Studies Find Promising Drug Candidates

Retrieved on: 
Friday, March 29, 2024
Hydralazine, Issue 1, DHT, Pigment, UBA52, Neuroregeneration, Prevalence, Apoptosis, PNI, Serum, Homeostasis, Patient, Ferroptosis, JPA, Neuron, HYD, Metformin, Type, Nerve, BPH, Hypopigmentation, EB, Depigmentation, Met, Oxidative stress, Iron, Pharmaceutical industry

XI'AN, China, March 29, 2024 /PRNewswire/ -- Understanding the underlying mechanisms of normal and pathological cellular processes is essential for developing new drugs. Fortunately, modern techniques and experimental methods have greatly accelerated progress. The latest issue of JPA features three articles in which candidate compounds for treating complex disorders were successfully identified, alongside their detailed mechanisms of action.

Key Points: 
  • The first study investigated the use of metformin (Met), a drug used to manage type II diabetes, for treating benign prostate hyperplasia (BPH).
  • The article was published in Volume 14, Issue 1 of the journal in January 2024 .
  • Using the Drug Signatures Database, they identified hydralazine (HYD), a potent arterial vasodilator, as a potential UBA52 disruptor.
  • Further studies will hopefully clarify the intricate connections among cellular processes, diseases, and potential drugs, paving the way for precise and efficient therapies.

Global and China Hybrid Electric Vehicle (HEV) Research Report 2023-2024: In 2025, the Share of Plug-in/Extended-range Hybrid Electric Passenger Cars by Sales in China is Expected to Rise to 40%

Retrieved on: 
Friday, March 15, 2024
IAA, DHT, Bev, GM, BYD, Great Wall of China, BEV, Li Auto, Original equipment manufacturer, Volkswagen, Research, Anxiety, Ford, BorgWarner, Carbon, Geely, ICE, HEM, Research report, HEV, Dongfeng, GAC, DHE, PHEV, REEV, Electric motor

DUBLIN, March 15, 2024 /PRNewswire/ -- The "Global and China Hybrid Electric Vehicle (HEV) Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 15, 2024 /PRNewswire/ -- The "Global and China Hybrid Electric Vehicle (HEV) Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.
  • In China, plug-in/extended-range hybrid electric passenger cars already make up 30.6% of new energy passenger cars.
  • As new models continue to emerge, the sales of plug-in/extended-range hybrid electric passenger cars will be on the rise.
  • It is expected that by 2025, plug-in/extended-range hybrid electric passenger cars will take up 40% of the new energy passenger car sales in China.

Celluma Light Therapy Introduces the RESTORE Hair Therapy System

Retrieved on: 
Thursday, March 14, 2024
DHT, Vitamin, Adenosine triphosphate, Serum, Inflammation, Zinc, Hair loss, Glycine, Scalp, ATP, FDA, Microcirculation, Peptide, Cosmetics

TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.

Key Points: 
  • TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.
  • "It's an amazingly elegant formulation that is clear and easily absorbed into the scalp so that it can be used daily to maximize the Celluma Light Therapy results."
  • For the growing number of professionals and individuals achieving significant and visible results with the FDA-cleared Celluma RESTORE Light Therapy device for hair restoration, this serum is an ideal complement for use between each light therapy treatment.
  • According to Mr. Cluff, "the Celluma RESTORE light therapy device has been available since receiving FDA-clearance for hair restoration in 2021.

DHT orders four large VLCCs

Retrieved on: 
Wednesday, February 28, 2024
Ship, Investment, Ageing, Transport, DHT, Policy, VLCC, Warehouse

HAMILTON, BERMUDA, February 28, 2024 – DHT Holdings, Inc. (NYSE:DHT) (the “Company”) today announced it has entered into agreements to build four large VLCCs.

Key Points: 
  • HAMILTON, BERMUDA, February 28, 2024 – DHT Holdings, Inc. (NYSE:DHT) (the “Company”) today announced it has entered into agreements to build four large VLCCs.
  • The Company has entered into agreements to build four large VLCCs for delivery between April and December 2026.
  • Two will be constructed at each Hyundai Samho Heavy Industries and Hanwha Ocean (formerly known as Daewoo Shipbuilding & Marine Engineering), in South Korea.
  • The vessel supply scenario for the VLCC sector is very constructive:
    The current orderbook with the supply of new VLCCs equals less than 3% of the existing fleet.

REMINDER - Leading LNG, LPG, Crude & Product Tanker Shipping Companies Participating at Capital Link’s 18th Annual International Shipping Forum Monday, March 11, 2024 in New York City

Retrieved on: 
Monday, February 26, 2024
ASC, Marketing, CPLP, Forum, FLNG, STNG, DHT, LPG, FLEX

It is a meeting place for C-level Executives from the maritime industry and the finance and investment communities involved with shipping.

Key Points: 
  • It is a meeting place for C-level Executives from the maritime industry and the finance and investment communities involved with shipping.
  • Discussions will include topics of critical relevance to the industry geopolitics, energy security, sanctions, access to capital, regulation, technology, innovation and more.
  • The Forum features a series of panel discussions as well as 1x1 meetings between investors and executives from shipping companies.
  • This one-day conference is known for its rich informational content and the extensive marketing, networking and business development opportunities.

DHT Holdings, Inc. Fourth Quarter 2023 Results

Retrieved on: 
Tuesday, February 6, 2024
DHT

HAMILTON, BERMUDA, February 6, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended December 31, 2023.

Key Points: 

HAMILTON, BERMUDA, February 6, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended December 31, 2023.
The full report is available here and in the below attachment.

Dermal Repair Complex from Beverly Hills MD Can Help Nourish Dry Skin This Winter

Retrieved on: 
Tuesday, February 6, 2024
DHT, Collagen loss, Hyaluronic acid, MSM, Cell, Dietary supplement, Ageing, Vitamin A, Skin, Water, Neck, Elasticity, Capsule, Antioxidant, Dicarboxylic acid, Methylsulfonylmethane, Chin

BEVERLY HILLS, Calif., Feb. 6, 2024 /PRNewswire/ -- As Winter temperatures begin to drop, many of us find that the cold weather can bring on a set of challenges, particularly for our skin. The harsh winter conditions often leave us grappling with dry skin, causing plump skin cells to shrivel and potentially leading to fine lines and wrinkles.

Key Points: 
  • One such supplement is the Beverly Hills MD Dermal Repair Complex.
  • Beverly Hills MD Dermal Repair Complex is a dietary supplement designed to revitalize the look of skin from the inside out.
  • As we bid farewell to winter, it's time to consider incorporating such skincare solutions to help rejuvenate and nourish the skin for the upcoming seasons.†*
    What is Beverly Hills MD Dermal Repair Complex?
  • Beverly Hills MD Dermal Repair Complex is a dietary supplement crafted with an advanced blend of scientifically-backed nutrients.

DHT Holdings, Inc. announces appointment of Ms. Ana Zambelli to the Board of Directors

Retrieved on: 
Thursday, February 1, 2024
Petrobras, Maersk Drilling, DHT, Transocean, Heriot-Watt University, Columbia University, Equity (finance), IBP, Management

HAMILTON, BERMUDA, February 1, 2024 – DHT Holdings, Inc. (NYSE:DHT) (the “Company”) today announced the appointment of Ms. Ana Zambelli to the Board of Directors, effective February 1, 2024.

Key Points: 
  • HAMILTON, BERMUDA, February 1, 2024 – DHT Holdings, Inc. (NYSE:DHT) (the “Company”) today announced the appointment of Ms. Ana Zambelli to the Board of Directors, effective February 1, 2024.
  • Ms. Ana Zambelli brings significant experience with more than 20 years in the energy sector in operational, commercial and finance roles.
  • Currently Ms. Zambelli serves as an independent board member for Seadrill, Galp and BW Energy.
  • Ms. Ana Zambelli graduated in mechanical engineering from the Federal University of Rio de Janeiro, and she holds a master’s degree in petroleum engineering from Heriot Watt University in the UK.

DHT Holdings, Inc. to announce fourth quarter 2023 results on Tuesday, February 6, 2024

Retrieved on: 
Tuesday, January 30, 2024
Call Me, DHT, Webcast, PIN

HAMILTON, BERMUDA, January 30, 2024 - DHT Holdings, Inc. (NYSE: DHT or the “Company”) will release its fourth quarter 2023 results after market close on Tuesday, February 6, 2024.

Key Points: 
  • HAMILTON, BERMUDA, January 30, 2024 - DHT Holdings, Inc. (NYSE: DHT or the “Company”) will release its fourth quarter 2023 results after market close on Tuesday, February 6, 2024.
  • The Company will host a conference call and webcast, which will include a slide presentation, at 8:00 a.m. EST/14:00 CET on Wednesday, February 7, 2024, to discuss the results for the quarter.
  • Participants will need to use the conference access information provided in the e-mail received at the point of registering.
  • Participants may also use the Call Me feature instead of dialing the nearest dial-in number.